Target intelligence / Profile preview

Septin-9 (SEPTIN9)

Target
SEPTIN9
Molecular classification
Cytoskeletal GTPase, Scaffold protein, Filament-forming protein, Septin family member
01

Overview

Septin-9 is a member of the highly conserved septin family of GTPases that form hetero-oligomeric complexes and filaments within the cytoskeleton[1][2][3][4][5]. It is essential for organizing actin and microtubule networks, playing a key role in cytokinesis, cell polarity, vesicle traffic, and membrane dynamics[1][2][3][5]. Septin-9 also interacts with other proteins to scaffold cellular processes and create diffusion barriers for compartmentalization. The protein participates in tumor suppression, but its dysregulation is implicated in oncogenesis, cancer progression, and resistance to certain chemotherapies[3][4]. The SEPTIN9 gene generates multiple isoforms via alternative splicing, further increasing its functional complexity[4][5]. Septin-9’s activity and expression patterns make it both a biomarker and potential therapeutic target for cancer, particularly colorectal cancer where SEPTIN9 methylation is used for noninvasive screening[3][4]. Its role in cell polarity, cytoskeleton regulation, and membrane structure is vital for normal development and tissue maintenance, as well as disease processes[1][2][3][4].

Other names
KIAA0991MSFSEPT9MLL septin-like fusion proteinOv/Br septinMSF1PNUTL4AF17q25SeptD1MSF-AOvarian/Breast septinpeanut-like 4NAPBSINT1
02

Mechanism of action

Disruption or stabilization of septin filaments alters cell division and cytoskeletal dynamics Modulation of microtubule or actin-associated functions can affect sensitivity to chemotherapeutic agents

03

Biological functions

CytokinesisCytoskeleton organizationCell cycle regulationCell polarity and membrane traffickingVesicle transport and fusionProtein compartmentalization and diffusion barriersTumor suppressionCilium organization and assembly
04

Disease associations

Cancer (including colorectal, breast, ovarian, and other malignancies)Tumor progression and metastasisChemoresistance (e.g., resistance to microtubule-targeting agents)
05

Safety considerations

Overexpression may contribute to tumor progression or chemoresistanceLoss of function can disrupt cell division leading to binuclear cells or abnormal tissue organization
06

Interacting drugs

2-Methoxyestradiol

2 more in the full profile.

07

Biomarkers

SEPTIN9 methylated DNA serves as a noninvasive biomarker for colorectal cancer screeningExpression levels correlated with tumor progression and prognosis

Beyond the preview

Go deeper on Septin-9 (SEPTIN9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin-9 (SEPTIN9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call